AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H283-H289, 2003. First published September 5, 2002; doi:10.1152/ajpheart.00461.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
284/1/H283    most recent
00461.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Besikci, A. O.
Right arrow Articles by Lopaschuk, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Besikci, A. O.
Right arrow Articles by Lopaschuk, G. D.
Vol. 284, Issue 1, H283-H289, January 2003

Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart

Arzu Onay Besikci*, Fiona M. Campbell*, Teresa A. Hopkins, Jason R. B. Dyck, and Gary D. Lopaschuk

Departments of Pharmacology and Pediatrics, University of Alberta, Edmonton, Alberta, Canada T6G 2S2


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

After birth, a dramatic increase in fatty acid oxidation occurs in the heart, which has been attributed to an increase in L-carnitine levels and a switch from the liver (L) to muscle (M) isoform of carnitine palmitoyltransferase (CPT)-1. However, because M-CPT-1 is more sensitive to inhibition by malonyl CoA, a potent endogenous regulator of fatty acid oxidation, a switch to the M-CPT-1 isoform should theoretically decrease fatty acid oxidation. Because of this discrepancy, we assessed the contributions of myocardial L-carnitine content and CPT-1 isoform expression and kinetics to the maturation of fatty acid oxidation in newborn rabbit hearts. Although fatty acid oxidation rates increased between 1 and 14 days after birth, myocardial L-carnitine concentrations did not increase. Changes in the expression of L-CPT-1 or M-CPT-1 mRNA after birth also did not parallel the increase in fatty acid oxidation. The Km of CPT-1 for carnitine and the IC50 for malonyl CoA remained unchanged between 1 and 10 days after birth. However, malonyl CoA levels dramatically decreased, due in part to an increase in malonyl CoA decarboxylase activity. Our data suggest that a decrease in malonyl CoA control of CPT-1 is primarily responsible for the increase in fatty acid oxidation seen in the newborn heart.

carnitine palmitoyltransferase-1; pyruvate dehydrogenase; acetyl CoA carboxylase; glucose oxidation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

FATTY ACID OXIDATION in the newborn heart matures rapidly after birth (16, 29). For example, in 1-day-old rabbit hearts, fatty acid oxidation rates are very low and contribute <10% of the overall ATP production (17). However, by 7 days of age, fatty acid oxidation dramatically increases and becomes the predominant source of energy production. What is responsible for this increase in fatty acid oxidation has not been completely delineated, although an increase in the mitochondrial uptake of fatty acids has been implicated in this process (1, 9, 18). The transport of fatty acids into the mitochondria is primarily controlled at the level of carnitine palmitoyl transferase-1 (CPT-1) (20). CPT-1 is in turn inhibited by malonyl CoA and stimulated by L-carnitine (1, 20, 22, 27, 28). The heart expresses two isoforms of CPT-1, L-CPT-1 and M-CPT-1, with L-CPT-1 being less sensitive to inhibition by malonyl CoA and requiring lower L-carnitine concentrations for maximal stimulation (20, 22, 27, 28).

The dramatic increase in fatty acid oxidation seen in the newborn heart has been attributed to an increase in L-carnitine levels and a switch from the L-CPT-1 isoform to the M-CPT-1 isoform (1). However, because M-CPT-1 is more sensitive to inhibition by malonyl CoA, this switch should actually lead to a decrease in fatty acid oxidation rates, not an increase as previously observed (17, 18, 29). An alternate explanation for the increase in fatty acid oxidation is a decrease in myocardial malonyl CoA levels after birth, resulting in a decrease in malonyl CoA inhibition of CPT-1. Indeed, we have previously shown that after birth, malonyl CoA levels do dramatically decrease in the newborn heart. In 1-day-old rabbit hearts, malonyl CoA levels are very high but decrease dramatically by 7 days after birth (5, 18, 19). These changes in malonyl CoA can be explained by alterations in the control of both malonyl CoA synthesis and degradation (5, 16, 18, 19).

Malonyl CoA is synthesized in the heart by acetyl CoA carboxylase (ACC), the activity of which decreases in the heart after birth (18). ACC is in turn phosphorylated and inactivated by AMP-activated protein kinase (AMPK) (12), the activity and expression of which increases in the heart after birth (19). Malonyl CoA is degraded in the heart by decarboxylation to acetyl CoA by malonyl CoA decarboxylase (MCD) (16). The relative importance of changes in MCD and ACC control of malonyl CoA versus changes in L-carnitine control of CPT-1 or alterations in CPT-1 activity/expression to the increase in fatty acid oxidation in the newborn heart is not clear.

In addition to fatty acid oxidation, glucose oxidation is an important source of energy for the adult heart. In contrast to fatty acid oxidation after birth, rates of glucose oxidation are low in the newborn heart (17) and do not fully mature until after weaning (29). Pyruvate decarboxylation is the key rate-limiting irreversible step in glucose oxidation and is catalyzed by the pyruvate dehydrogenase (PDH) multienzyme complex. Activity of PDH is controlled by kinase-mediated inactivation, responsive to acetyl CoA-to-CoA and NADH-to-NAD+ ratios and phosphatase-mediated activation, which responds to mitochondrial calcium and magnesium concentrations (23). In the adult heart, fatty acids are potent inhibitors of glucose oxidation in the heart, secondary to an increase in the acetyl CoA-to-CoA and NADH-to-NAD+ ratios that result from the oxidation of fatty acids (23). Whether glucose oxidation remains low in the newborn heart due to a delay in the maturation of the enzymes involved in glucose oxidation or to the increase in fatty acid oxidation is not known.

The first aim of this study was to determine the relative contributions of CPT-1 isoform expression, myocardial L-carnitine content, and the kinetics of CPT-1 to the maturation of fatty acid oxidation in the newborn heart. The second aim of this study was to determine whether the low glucose oxidation rates seen in the newborn period are due to a low PDH activity and/or a low capacity for glucose oxidation.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

Animals. Newborn New Zealand White rabbits between 1 and 14 days of age were used in this study.

Heart tissue isolation. Newborn rabbits were injected with 60 mg/kg ip pentobarbital sodium. Hearts from anesthetized rabbits were removed and placed in ice-cold Krebs-Henseleit solution. Hearts were then used for either the preparation of mitochondria, cannulated for isolated heart perfusions, or frozen immediately with tongs cooled in liquid N2. Frozen hearts were then ground using a mortar and pestle cooled to the temperature of liquid N2. A sample of frozen heart tissue (~20 mg) was weighed (wet wt) and then dried at 60°C overnight to remove all water (dry wt). The ratio of this sample (dry wt/wet wt) was used to calculate the total dry mass of the heart. Metabolic rates were calculated using the total dry mass of the heart to correct for variations in heart size.

Measurement of heart carnitine content. Samples of frozen tissue were powdered in liquid N2 and then homogenized in 3% perchloric acid, and, after centrifugation, the supernatant was neutralized with KOH. Free carnitine, short-chain acyl carnitine, and long-chain acyl carnitine were extracted from tissue as previously described (13). Carnitine levels were measured using a previously described radioisotopic assay (21).

CPT-1 isoform expression. The expression of M-CPT-1 and L-CPT-1 was measured by RT-PCR of total RNA isolated from neonatal frozen rabbit heart tissue. One microgram of RNA was used in the reactions. A PCR ELISA kit (Roche Diagnostics) was used for this analysis. This system allows for nonradioactive detection of PCR products in a microplate. It is based on the incorporation of digoxygenin (DIG)-labeled dUTP during PCR. These labeled PCR products were then bound to the streptavidin-coated surface of a microplate using biotin-labeled capture probes. The capture probes were designed to hybridize to the internal sequences of the PCR products. The DIG-labeled PCR products were detected with an anti-DIG-alkaline phosphatase conjugate and AttoPhos substrate using a fluorescence microplate reader. The primer sequences and biotin capture probe sequences used in these experiments were as follows: L-CPT-1, primer 1 5'-GTGAAGAAACAACCCCCAGA-3', primer 2 5'-GGAAGCACTTGAGACAAGCC-3', and biotin capture probe 5'-ATCACCTTGTTTGGCCTCAC-3'; and M-CPT-1, primer 1 5'-TGTCATGGCAACAGTTGGTT-3', primer 2 5'-TTGTCCTGGAATTCTTTGGC-3', and biotin capture probe 5'-CCGACAAGGTATGGCTCCTA-3'. The primers were designed from the published sequences for rat M-CPT-1 and L-CPT-1. DNA and protein homology searches were performed with BLAST using GenEMBL or SWISS-PROT databases.

Preparation of mitochondria. Mitochondria were prepared by differential centrifugation using a modified method of Power et al. (24). Briefly, hearts from 1-, 7-, and 10-day-old rabbit hearts were excised and finely minced with scissors in 10 ml of homogenization buffer (0.25 M sucrose, 5 mM Tris · HCl, and 1 mM EGTA; pH 7.4). Two hearts were pooled in the preparation of the mitochondria from 1-day-old hearts due to the low yield. The crude homogenate was centrifuged at 800 g for 10 min at 4°C. The resulting pellet was washed by resuspension in 2 vol of homogenization buffer and was then recentrifuged at 800 g. This step was repeated twice to maximize the yield of mitochondria. The combined supernatants were centrifuged at 6,000 g for 15 min, and the resultant pellet was carefully resuspended in 2 ml of homogenization buffer and centrifuged at 6,000 g for 15 min. The resultant pellet (crude mitochondria) was gently resuspended in 2 ml of homogenization buffer. The crude mitochondrial fraction (0.5 ml) was layered onto 9 ml of 30% Percoll and centrifuged at 50,000 g for 60 min at 4°C. The bottom mitochondrial protein band was collected.

Assay of CPT-1 activity. CPT-1 activity was assayed in the direction of acyl carnitine formation using palmitoyl CoA and carnitine as substrates (8). The final concentrations in the assay were 75 µM palmitoyl CoA, 0.01-1.5 mM carnitine (0.1-20 µCi/µmol L-[14C]carnitine), 4 mM ATP, 4 mM MgCl2, 0.25 mM glutathione, 40 µg/ml rotenone, 2 mM KCN, 15 mM KCl, 1% (wt/vol) BSA, and 105 mM Tris · HCl; pH 7.4. For malonyl CoA inhibition curves, the two substrates of CPT-1, palmitoyl CoA (75 µM) and L-carnitine (0.2 mM), were used at saturating concentrations in the presence of varying concentrations of malonyl CoA ranging from 0 to 1 µM.

MCD activity. MCD activity was measured in rabbit heart tissue using a radiometric assay as described previously (5).

Heart perfusions. Isolated working hearts obtained from 1- and 7-day-old rabbits were used for direct measurement of fatty acid and glucose oxidation as described previously (5, 14, 16, 18). Hearts were perfused with Krebs-Henseleit solution containing 11 mM glucose and 0.4 mM palmitate, prebound to 3% BSA. The perfusate pressure was 60 mmHg, and the time of perfusion was 40 min. Rates of fatty acid and glucose oxidation were measured in separate sets of hearts. Glucose oxidation rates were determined as previously described by trapping and measuring 14CO2 released by the metabolism of [U-14C]glucose in the presence or absence of 0.4 mM palmitate (14). Steady-state rates of palmitate oxidation were measured hearts by quantitatively collecting 14CO2 produced from hearts perfused with [1-14C]palmitate. Metabolic values were normalized for heart mass (dry wt).

PDH activity. PDH activity (both activated and total activity) was measured using a revised protocol (2) based on the radiometric assay described by Constantin-Teodosiu et al. (3).

Statistical analysis. Data are expressed as means ± SE. Comparisons were performed using Student's t-test. Significance was set at P < 0.05. For groups of four or more, ANOVA followed by the Tukey-Kramer multiple-comparisons test was used.


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

L-Carnitine content in newborn hearts. The amounts of free carnitine, long-chain acyl carnitine, and short-chain acyl carnitine in 1-, 4-, 10-, and 14-day-old rabbits are shown in Table 1. Myocardial free carnitine content did not vary dramatically among these four age groups. An increase in short-chain acyl carnitine and a decrease in long-chain acyl carnitine was observed during maturation. However, total carnitine content did not vary dramatically among the four age groups. The cellular concentrations of carnitine were calculated based on a cytosolic space of 2 ml/g dry wt in heart muscle and assuming an equal distribution of carnitine between different subcellular compartments, as described by Idell-Wenger et al. (13). The myocardial carnitine concentrations were as follows: 1 day old, 1.83 mM; 4 days old, 1.36 mM; 10 days old, 2.09 mM; and 14 days old, 2.03 mM. Free carnitine concentrations were as follows: 1 day old, 0.6 mM; 4 days old, 0.55 mM; 10 days old, 0.95 mM; and 14 days old, 0.95 mM. These concentrations are all above the Km for either CPT-1 isoform expressed in the heart, making it unlikely that carnitine concentration was limiting for CPT-1 activity in the newborn period.

                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Carnitine content in newborn rabbit hearts

Values for the Km for carnitine have previously been determined in various tissues from the rat, guinea pig, dog, and human (22). These values have been found to have a wide range for both isoforms of CPT-1, with the rat liver showing the lowest Km for carnitine (32 µM) and the dog heart the highest (695 µM) (22). In a study by Cook et al. (4), regulation of CPT-1 gene isoforms has not been correlated with fatty acid oxidation in the fetal or newborn rat heart. However, previous studies using tissue homogenates, isolated mitochondria, or isolated perfused organs have shown that fatty acid oxidation of the hearts from rats, rabbits, pigs, and calves is very low. The capacity of the heart to oxidize fatty acids increases shortly after birth in these species (for an extensive review, see Ref. 9). Species differences, if any, should be limited with level of gene and/or mRNA expression and not reflected by differences in the maturation of fatty acid oxidation.

CPT-1 mRNA expression in the newborn heart. mRNA expression of M-CPT-1 and L-CPT-1 in newborn rabbit hearts is shown in Fig. 1. The expression of L-CPT-1 mRNA was increased in the first 3 days after birth but then returned to 1-day-old levels by day 10 (Fig. 1, top). In contrast, M-CPT-1 expression was very low in 1-, 3-, and 7-day-old hearts but increased in 10- and 14-day-old hearts (Fig. 1, bottom). While the expression pattern of mRNA of the two isoforms of CPT-1 did show changes in the developing rabbit heart, it is unlikely a switch in CPT-1 from the L-CPT-1 to M-CPT-1 isoform can explain the increase in fatty acid oxidation observed during this period. The maturation of fatty acid oxidation in the newborn heart occurs between 1 and 7 days (from 22.6 ± 5.6 nmol · g dry wt-1 · min-1 in 1-day-old hearts to 299 ± 46 nmol · g dry wt-1 · min-1 in 7-day-old hearts). This increase in fatty acid oxidation precedes the increase in M-CPT-1 expression we observed in these hearts.


View larger version (13K):
[in this window]
[in a new window]
  		Fig. 1.   Expression of mRNA for the carnitine palmitoyl transferase-1 (CPT-1) isoforms. Expression was measured using RT-PCR ELISA as described in METHODS. Top: L-CPT-1. Results are expressed relative to the level in 1-day-old hearts. All experiments were carried out in duplicate, and results are the mean determinations of 4 different rabbit hearts for each age. Bottom: M-CPT-1. Results are expressed relative to the level in 1-day-old hearts. All experiments were carried out in duplicate, and results are the mean determinations of 4 different rabbit hearts for each age. * Significantly different from 1-day-old hearts.

It is possible that the increase in L-CPT-1 that occurred during the first few days after birth may have some role to play in the maturation of fatty acid oxidation in this period. However, this increase was transient, with L-CPT-1 expression appearing to decrease as M-CPT-1 expression increased. The recent study by Cook et al. (4) suggests a differential regulation of the two CPT-1 genes in the rat heart. These investigators showed a decline in the expression of the L-CPT-1 isoform during maturation and no change in the expression of M-CPT-1 (4). These results differ somewhat from our results, although neither expression pattern could explain the observed increase in fatty acid oxidation seen after birth.

Kinetics of CPT-1 in newborn rabbit heart mitochondria. The effects of various L-carnitine concentrations on CPT-1 activity in 1-, 7-, and 10-day-old rabbit hearts is shown in Fig. 2. In heart mitochondria obtained from all three age groups, increasing L-carnitine concentration resulted in an increase in CPT-1 activity. In 1- and 7-day-old hearts, the Vmax for CPT-1 was similar despite a 10-fold increase in fatty acid oxidation during this period. However, in 10-day-old hearts, CPT-1 activity at higher L-carnitine concentrations was significantly greater than rates in 1- and 7-day-old hearts. This may reflect the increased expression of M-CPT-1 observed in these hearts compared with 1-day-old hearts (Fig. 1, bottom).


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 2.   CPT-1 activity and corresponding Eadie-Hofstee plots at different ages. CPT-1 activity (left) was measured in mitochondria of newborn rabbit heart as described in METHODS. Values are means ± SE of 5 experiments in which 2 hearts were pooled to increase the mitochondrial yield for 1-day-old rabbits, 5 hearts for 7-day-old rabbits, and 8 hearts for 10-day-old rabbits. Right: Eadie-Hofstee plots used to determine the Km for carnitine. * Significantly different from 1-day-old hearts at compared carnitine concentrations; dagger  significantly different from 7-day-old hearts at compared carnitine concentrations.

Values for the Km for carnitine were obtained from Eadie-Hofstee plots (Fig. 2, right). Of interest was the observation that CPT-1 activity in mitochondria from 1- and 10-day-old hearts appeared to express two different Kms for L-carnitine, whereas the best fit for 7-day-old hearts was a single Km for L-carnitine. The reasons for the different Km characteristics are not clear and cannot be readily explained by the differential expression patterns of L-CPT-1 (which has a low Km for L-carnitine) or M-CPT-1 (which has a high Km for L-carnitine) in the newborn heart.

Of significance to this study is that even the highest Km values are below the concentrations of L-carnitine to which the newborn heart is exposed. Furthermore, there is no correlation between Km values for L-carnitine and the ability of the newborn heart to oxidize fatty acids (14, 17, 18). As a result, increased myocardial concentrations of L-carnitine, changes in CPT-1 isoform expression, and/or changes in the affinity of CPT-1 for L-carnitine are unlikely to be responsible for the dramatic increase in fatty acid oxidation seen in the newborn period.

It has been previously shown that electrical stimulation of isolated rat neonatal cardiac myocytes results in increased expression of M-CPT-1 and a greater sensitivity of CPT-1 to malonyl CoA inhibition (30). We found no difference in CPT-1 activity or sensitivity to inhibition by malonyl CoA in 7-day-old hearts compared with 1-day-old hearts. This is not surprising because we did not observe increased M-CPT-1 expression until 10 days after birth. It is therefore unlikely that a switch in CPT-1 isoform is responsible for the elevated levels of fatty acid oxidation seen in 7-day-old hearts.

Malonyl CoA inhibition of CPT-1 in rabbit heart mitochondria. We also determined whether changes in the sensitivity of CPT-1 to inhibition by malonyl CoA occur in the newborn heart. Malonyl CoA inhibition of CPT-1 activity was measured in mitochondria obtained from 1- and 10-day-old hearts (Fig. 3). In these experiments, mitochondria were exposed to 200 µM L-carnitine. Similar to the findings shown in Fig. 2, CPT-1 activity in the absence of malonyl CoA was higher in mitochondria from 10-day-old hearts compared with 1-day-old hearts. The addition of malonyl CoA resulted in a marked inhibition of CPT-1 activity (~95%). Despite this marked inhibition by malonyl CoA, there was no significant difference in the sensitivity of CPT-1 to malonyl CoA inhibition between 1- and 10-day-old hearts. The IC50 values for malonyl CoA were 4 and 5 nM in 1- and 10-day-old rabbit hearts, respectively.


View larger version (16K):
[in this window]
[in a new window]
  		Fig. 3.   Malonyl CoA inhibition of CPT-1 activity. CPT-1 activity was measured in mitochondria of the newborn rabbit heart as described in METHODS. Values are means ± SE of 8 experiments in 1-day-old hearts and 8 experiments in 10-day-old hearts.

Although the sensitivity to malonyl CoA did not differ between these two age groups, previous studies from our laboratory have demonstrated that there is a dramatic reduction in malonyl CoA levels between 1- and 7-day-old hearts (122.0 ± 8.3 nmol/g dry wt in 1-day-old rabbit hearts vs. 1.4 ± 0.5 nmol/g dry wt in 7-day-old rabbit hearts). This decrease in malonyl CoA is accompanied by a 10-fold increase in fatty acid oxidation (1, 3). As a result, our data support the concept that it is a drop in malonyl CoA levels in the newborn heart that is probably the most important determinant of flux through CPT-1 and the increase in fatty acid oxidation in the newborn heart.

Malonyl CoA degradation in the newborn heart. We have previously demonstrated that acetyl CoA carboxylase is the key source of malonyl CoA synthesis in the heart (25) and that the decrease in malonyl CoA seen in the newborn heart is accompanied by a decrease in ACC activity (18). Because MCD is the key mechanism by which malonyl CoA is degraded in the heart (5, 6, 11), we measured MCD activity changes in newborn rabbit hearts of different ages. As shown in Fig. 4, the activity of MCD increased in the heart in an age-dependent manner. This increase in MCD activity was almost maximally increased in 7-day-old hearts, a time period in which malonyl CoA levels dramatically decrease (18) and fatty acid oxidation rates dramatically increase (17). This suggests that a drop in malonyl CoA and a decrease in malonyl CoA inhibition of CPT-1 may be one of the key mechanisms responsible for the maturation of fatty acid oxidation after birth.


View larger version (14K):
[in this window]
[in a new window]
  		Fig. 4.   Malonyl CoA decarboxylase (MCD) activity in newborn rabbit hearts. MCD was measured in newborn rabbit hearts as described in METHODS. Values are means ± SE of 5 hearts in each group. * Significantly different from 1-day-old hearts; dagger  significantly different from 2-day-old hearts; asignificantly different from 3-day-old hearts; bsignificantly different from 5-day-old hearts.

The data from this study and our previous studies (5, 18) suggest that an increase in ACC activity and a decrease in MCD activity are primarily responsible for the dramatic decrease in myocardial malonyl CoA levels in the newborn heart. The decrease in ACC activity in the newborn heart appears to be primarily due to an increased activity and expression of AMPK in the newborn heart (15, 19). AMPK activity/expression increases dramatically in the immediate newborn period, resulting in a phosphorylation and inactivation of ACC (15, 19). The increase in MCD activity may be entirely due to increased MCD protein expression in the heart after birth (5). Alternatively, it is also possible that the increase in AMPK after birth may activate MCD. Saha et al. (26) have shown that AMPK can phosphorylate and activate skeletal muscle MCD in skeletal muscle. However, we and others have not been able to reproduce this finding in either the adult heart (7) or skeletal muscle (10). Whether AMPK regulates MCD in the newborn heart remains to be determined. However, based on the data provided here, we propose the scheme shown in Fig. 5.


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 5.   Proposed pathway by which fatty acid oxidation increases in the newborn heart. A decrease in acetyl CoA carboxylase (ACC) activity and an increase in MCD activity shortly after birth results in a dramatic drop in cardiac malonyl CoA levels. The decrease in ACC activity is due to a phosphorylation and inhibition of ACC by AMP-dependent kinase (AMPK). Decreased malonyl CoA levels relieves the inhibition of CPT-1, resulting in an increase in fatty acid oxidation.

Fatty acid control of glucose oxidation in the newborn heart. Whereas fatty acid oxidation increases dramatically after birth (probably due to a decrease in malonyl CoA levels), glucose oxidation (the other main source of acetyl CoA for the tricarboxylic acid cycle) does not increase during this period (17). Whether this is due to an increase in fatty acid inhibition of glucose oxidation or due to a delayed maturation of the enzymes controlling glucose oxidation is not clear. We therefore determined what happens to the activity of myocardial PDH, the rate-limiting enzyme for glucose oxidation, in the newborn period. We measured both the active phosphorylated form of PDH as well as total PDH activity (Fig. 6). A progressive age-dependent increase in active PDH and total PDH was observed between 1-, 7-, and 10-day-old hearts, suggesting that the capacity for glucose oxidation increases in the newborn period.


View larger version (18K):
[in this window]
[in a new window]
  		Fig. 6.   Pyruvate dehydrogenase (PDH) activity in newborn rabbit hearts. PDH was measured in newborn rabbit hearts as described in METHODS. Values are means ± SE of 4 hearts/group. * Significantly different from 1-day-old hearts; dagger  significantly different from 7-day-old hearts.

To determine whether the increase in PDH was accompanied by an increase in glucose oxidation, isolated working hearts from 1- and 7-day-old hearts were used to measure glucose oxidation (Fig. 7). Perfusion of hearts in the absence of fatty acids, a condition that measures the maximal capacity of the heart to oxidize glucose, showed that the capacity of the heart to oxidize glucose increases dramatically between 1 and 7 days of age. This increase is consistent with the increase in PDH activity observed in Fig. 6. However, if hearts were perfused with physiologically relevant levels of fatty acids, glucose oxidation rates were very low in both 1- and 7-day-old hearts (Fig. 7). The dramatic increase in glucose oxidation observed in glucose-perfused hearts was completely prevented. This suggests that the newborn heart rapidly acquires the capability of oxidizing glucose but that glucose oxidation is inhibited due to the increase in fatty acid oxidation observed during this period. Therefore, the decrease in malonyl CoA observed after birth not only accelerates fatty acid oxidation but also inhibits glucose oxidation during this period. This inhibition of glucose oxidation likely occurs as a result of an inhibition of PDH that occurs as a result of the increase in fatty acid oxidation.


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 7.   Glucose oxidation rates measured in 1- and 7-day-old newborn rabbit hearts perfused in the presence or absence of 0.4 mM palmitate. Glucose oxidation was measured in newborn rabbit hearts as described in METHODS. Values are means ± SE of 6 hearts/group. *P < 0.05.

In summary, our results suggest that malonyl CoA has a key role in the maturation of fatty acid oxidation after birth. We demonstrate that a decrease in malonyl CoA, as opposed to changes in L-carnitine content, is responsible for the increase in fatty acid oxidation in the newborn heart. The decrease in malonyl CoA not only increases fatty acid oxidation but also results in glucose oxidation rates remaining low in the newborn period. These results highlight the key role of malonyl CoA in the control of cardiac energy metabolism.


    ACKNOWLEDGEMENTS

This work was funded by a grant from the Heart and Stroke Foundation of Alberta and Canadian Institutes for Health Research. F. M. Campbell is an Alberta Heritage Foundation for Medical Research postdoctoral fellow. J. R. B. Dyck is an Alberta Heritage Foundation for Medical Research Scholar. G. D. Lopaschuk is an Alberta Heritage Foundation for Medical Research Medical Scientist.


    FOOTNOTES

* A. O. Besikci and F. M. Campbell contributed equally to this work.

Address for reprint requests and other correspondence: G. D. Lopaschuk, 423 Heritage Medical Research Center, Univ. of Alberta, Edmonton, Alberta, Canada T6G 2S2 (E-mail: gary.lopaschuk{at}ualberta.ca).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published September 5, 2002;10.1152/ajpheart.00461.2002

Received 18 June 2002; accepted in final form 30 August 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

1.   Brown, NF, Weis BC, Husti JE, Foster DW, and McGarry JD. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 270: 8952-8957, 1995[Abstract/Free Full Text].

2.   Collins-Nakai, RL, Noseworthy D, and Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol Heart Circ Physiol 267: H1862-H1871, 1994[Abstract/Free Full Text].

3.   Constantin-Teodosiu, D, Cederblad G, and Hultman E. A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem 198: 347-351, 1991[ISI][Medline].

4.   Cook, GA, Edwards TL, Jansen MS, Bahouth SW, Wilcox HG, and Park EA. Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart. J Mol Cell Cardiol 33: 317-329, 2001[ISI][Medline].

5.   Dyck, JRB, Barr AJ, Barr R, Kolattukudy PE, and Lopaschuk GD. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol Heart Circ Physiol 275: H2122-H2129, 1998[Abstract/Free Full Text].

6.   Dyck, JRB, Berthiaume LG, Thomas PD, Kantor PF, Barr AJ, Barr R, Singh D, Hopkins TA, Voilley N, Prentki M, and Lopaschuk GD. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism. Biochem J 350: 599-608, 2000[Medline].

7.   Dyck, JRB, Kudo N, Barr AJ, Davies SP, Hardie DG, and Lopaschuk GD. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. Eur J Biochem 262: 184-190, 1999[ISI][Medline].

8.   Esser, V, Britton C, H, Weis BC, Foster DW, and McGarry JD. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase. I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J Biol Chem 268: 5817-5822, 1993[Abstract/Free Full Text].

9.   Girard, J, Ferré P, Pégorier JP, and Duée PH. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 72: 507-562, 1992[Free Full Text].

10.   Habinowski, SA, Hirshman M, Sakamoto K, Kemp BE, Gould SJ, Goodyear LJ, and Witters LA. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch Biochem Biophys 396: 71-79, 2001[ISI][Medline].

11.   Hamilton, C, and Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes. Biochem J 350: 61-67, 2000[ISI][Medline].

12.   Hardie, DG. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim Biophys Acta 1301: 231-238, 1992.

13.   Idell-Wenger, JA, Grotyohann LW, and Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310-4318, 1978[Abstract/Free Full Text].

14.   Itoi, T, and Lopaschuk GD. Calcium improves mechanical function and carbohydrate metabolism following ischemia in isolated bi-ventricular working hearts from immature rabbits. J Mol Cell Cardiol 28: 1501-1514, 1996[ISI][Medline].

15.   Kantor, PF, Robertson MA, Coe JY, and Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol 33: 1724-1734, 1999[Abstract/Free Full Text].

16.   Lopaschuk, GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994[Medline].

17.   Lopaschuk, GD, and Spafford MA. Energy substrate utilization by isolated working hearts from newborn rabbits. Am J Physiol Heart Circ Physiol 258: H1274-H1280, 1990[Abstract/Free Full Text].

18.   Lopaschuk, GD, Witters LA, Itoi T, Barr R, and Barr AJ. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J Biol Chem 269: 25871-25878, 1994[Abstract/Free Full Text].

19.   Makinde, AO, Gamble J, and Lopaschuk GD. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res 80: 482-489, 1997[Abstract/Free Full Text].

20.   McGarry, JD, and Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49: 395-420, 1980[ISI][Medline].

21.   McGarry, JD, and Foster DW. Free and esterified carnitine: radiometric method. In: Methods of Enzyme Analysis, edited by Bergmeyer HU.. Weinheim, Germany: Academic, 1985, p. 474-481.

22.   McGarry, JD, Mills SE, Long CS, and Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28, 1983[ISI][Medline].

23.   Patel, MS, and Roche TE. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 4: 3224-3233, 1990[Abstract].

24.   Power, GW, Yaqoob P, Harvey DJ, Newsholme EA, and Calder PC. The effect of dietary lipid manipulation on hepatic mitochondrial phospholipid fatty acid composition and carnitine palmitoyltransferase I activity. Biochem Mol Biol Int 34: 671-684, 1994[ISI][Medline].

25.   Saddik, M, Gamble J, Witters LA, and Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993[Abstract/Free Full Text].

26.   Saha, AK, Schwarsin AJ, Roduit R, Masse F, Kaushik V, Tornheim K, Prentki M, and Ruderman NB. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 275: 24279-24283, 2000[Abstract/Free Full Text].

27.   Weis, BC, Cowan AT, Brown N, Foster DW, and McGarry JD. Use of a selective inhibitor of liver carnitine palmitoyltranferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269: 26443-26448, 1994[Abstract/Free Full Text].

28.   Weis, BC, Esser V, Foster DW, and McGarry JD. Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase. I. The minor component is identical to the liver enzyme. J Biol Chem 269: 18712-18715, 1994[Abstract/Free Full Text].

29.   Werner, JC, Sicard RE, and Schuler HG. Palmitate oxidation by isolated working fetal and newborn pig hearts. Am J Physiol Endocrinol Metab 256: E315-E321, 1989[Abstract/Free Full Text].

30.   Xia, Y, Buja LM, and McMillin JB. Change in expression of heart carnitine palmitoyltransferase I isoforms with electrical stimulation of cultured rat neonatal cardiac myocytes. J Biol Chem 271: 12082-12087, 1996[Abstract/Free Full Text].

Am J Physiol Heart Circ Physiol 284(1):H283-H289
0363-6135/03 $5.00 Copyright © 2003 the American Physiological Society


This article has been cited by other articles:


Home page
 NeoReviewsHome page
T. D. Scholz and J. L. Segar
Cardiac Metabolism in the Fetus and Newborn
NeoReviews, March 1, 2008; 9(3): e109 - e118.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. C. Stanley, E. E. Morgan, H. Huang, T. A. McElfresh, J. P. Sterk, I. C. Okere, M. P. Chandler, J. Cheng, J. R. B. Dyck, and G. D. Lopaschuk
Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2304 - H2309.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. N. Lavrentyev, D. He, and G. A. Cook
Expression of genes participating in regulation of fatty acid and glucose utilization and energy metabolism in developing rat hearts
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2035 - H2042.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
284/1/H283    most recent
00461.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Besikci, A. O.
Right arrow Articles by Lopaschuk, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Besikci, A. O.
Right arrow Articles by Lopaschuk, G. D.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online